CRISPR Therapeutics AG (CRSP) Current Taxes (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported Current Taxes of $638000.0 for Q1 2026, down 48.59% on a YoY basis from $1.2 million in Q1 2025, and down 42.68% sequentially from $1.1 million in Q4 2025.
CRISPR Therapeutics AG (CRSP) Current Taxes (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 12 years of Current Taxes data on file, last reported at $638000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes fell 48.59% year-over-year to $638000.0; the trailing twelve-month figure through Mar 2026 stood at $638000.0 (down 48.59% YoY), and the FY2025 full-year result was $1.1 million, up 146.78% from the prior year.
- Current Taxes retreated to $638000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $4.3 million in Q3 2022 to a low of $135000.0 in Q4 2022.
- A 5-year average of $1.3 million and a median of $715000.0 in 2025 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes sank 95.88% in 2023 and jumped 376.14% in 2024, its largest moves.
- Tracing CRSP's Current Taxes over 5 years: stood at $135000.0 in 2022, then soared by 224.44% to $438000.0 in 2023, then climbed by 2.97% to $451000.0 in 2024, then jumped by 146.78% to $1.1 million in 2025, then plunged by 42.68% to $638000.0 in 2026.
- Business Quant data shows CRSP's Current Taxes at $638000.0 in Q1 2026, $1.1 million in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | 638,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 638,000.00 |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 715,000.00 |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 451,000.00 |
| Sep 30, 2024 | 838,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 438,000.00 |
| Sep 30, 2023 | 176,000.00 |
| Jun 30, 2023 | 558,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | 4.27 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 724,000.00 |
| Sep 30, 2021 | 3.27 Mn |
| Jun 30, 2021 | 4.46 Mn |